Epicardial access system and methods

Information

  • Patent Grant
  • 11766290
  • Patent Number
    11,766,290
  • Date Filed
    Tuesday, September 8, 2020
    4 years ago
  • Date Issued
    Tuesday, September 26, 2023
    12 months ago
Abstract
A method and apparatus are disclosed for a needle for gaining access to the pericardial cavity of a heart. The needle includes an elongate member (e.g. a main shaft) defining a lumen and a side-port in fluid communication with the lumen; a blunt atraumatic tip for delivering energy for puncturing tissue; and a guiding surface (e.g. a ramp) for directing a device (e.g. a guidewire) through the side-port. The method includes using the needle for tenting a pericardium and delivering energy for puncturing the pericardium, and advancing a guidewire or other device through the needle and into the pericardial cavity.
Description
TECHNICAL FIELD

This disclosure relates to the field of surgical needles. More specifically, this disclosure relates to surgical needles that use energy for puncturing.





BRIEF DESCRIPTION OF THE DRAWINGS

In order that the invention may be readily understood, embodiments of the invention are illustrated by way of examples in the accompanying drawings, in which:



FIG. 1, consisting of FIGS. 1A-1D, as well as detail views A-V1, A-V2, C1 and C2, is an illustration of a needle having a side-port in accordance with an embodiment of the invention;



FIG. 2, including detail views 2A-2C, is an illustration of a needle having a side-port in accordance with an alternative embodiment of the invention;



FIG. 3, consisting of FIGS. 3A-3H, is an illustration showing the steps in a method of using a needle in accordance with an embodiment of the invention;



FIG. 4, consisting of FIGS. 4A-4F, is an illustration showing the use of ECG in accordance with an embodiment of the invention;



FIG. 5 is an illustration showing an enlarged view of a side-port in accordance with an embodiment of the invention;



FIG. 6, consisting of FIGS. 6A-6E, is an illustration showing the steps in a method of using a needle in accordance with an alternative embodiment of the invention; and



FIG. 7, consisting of FIGS. 7A-7D, shows ECG readings in accordance with an embodiment of the invention.





DETAILED DESCRIPTION

Minimally invasive access to the pericardial space is required for diagnosis and treatment of a variety of arrhythmias and other conditions. Access to the space may be initiated using a large diameter (for example, about 17 Ga) Tuohy-style needle via the subxiphoid approach. A guidewire (for example, about 0.032 inches (about 0.81 mm) in outer diameter) is then advanced to the heart through the needle lumen. After gaining access to the pericardial space, the operator removes the Tuohy needle then advances and secures a sheath (for example, 8.5 Fr) to facilitate use of treatment devices such as ablation and mapping catheters.


Mechanical puncture using large bore needles, as described above, is associated with a high clinical complication rate. Although the stiff needle provides some stability and some tactile feedback to the user, unwanted tissue damage is possible if the needle inadvertently punctures or unintentionally lacerates tissue.


As a consequence of the challenges and uncertainties of using mechanical puncture for accessing the pericardial space, physicians may resort to common endocardial ablation in situations where epicardial ablation is a preferred treatment, such as ventricular tachycardias. New devices or methods to improve the safety and predictability of gaining access to the pericardial space would be of benefit.


The problem of improving the ease of use, safety, and predictability of gaining access to the epicardium is solved, at least in part, by a needle for gaining epicardial access, the needle having an elongate member (e g a main shaft) defining a lumen and a side-port in fluid communication with the lumen; a blunt atraumatic tip for delivering energy for puncturing tissue; and a guiding surface (e.g. a ramp) for directing a device (e.g. a guidewire) through the side-port.


The present inventors have conceived, and reduced to practice, embodiments of such a medical device. Some embodiments of the needle have a blunt tip of 17, 18 19, or 19.5 Ga. The blunt tip prevents any premature mechanical puncture to the pericardium when pressed against it. Also, a needle with a blunt tip provides better tactile feedback than a needle with a sharp tip. The side-port allows delivery of contrast agent and facilitates deployment of a device (e.g. a guidewire) through the needle to confirm access to the pericardial space. Physicians typically use fluoroscopy to check that the guidewire (or other device) is wrapped around the heart to confirm pericardial access. Physicians may also confirm access via tactile feedback which may indicate incorrect needle position or obstruction. Physicians may also deliver contrast medium to confirm access and determine needle location.


In a first broad aspect, embodiments of the present invention comprise a needle for use with a device and for gaining epicardial access, the needle comprising: an elongate member which is comprised of a metal and defines a lumen and a side-port with a proximal edge, the side-port being in fluid communication with the lumen; an insulation covering an outside of the elongate member wherein a blunt tip of the needle is electrically exposed to define an electrode for delivering energy for puncturing tissue; a guiding surface extending from a side wall of the elongate member which is opposite to the side-port to define an end of the lumen, the guiding surface being configured for directing the device through the side-port; and an insulation portion covering a proximal part of the side-port defined by the elongate member to define an aperture which is smaller than the side-port, wherein the insulation portion is comprised of a polymer that is softer and less abrasive than the metal of the proximal edge.


As a feature of the first broad aspect, the needle is configured for delivering energy through a metal side wall of elongate member to the electrode. In some embodiments of this feature, the electrode has greater radiopacity than the elongate member. Some embodiments further comprise insulation on an inner surface of the elongate member adjacent to the side-port to reduce electrical leakage. Some embodiments include insulation on an inner surface of most or substantially all the elongate member to reduce electrical leakage. In some embodiments of this feature, a part of the elongate member adjacent and distal of the side-port is electrically exposed to define an elongate member exposed portion. Some examples include a distal edge of the side-port is located at a distance of about 0.050 to 0.125 inches (about 1.27 to 3.18 mm) from an electrode distal tip. In some such examples, the distal edge of the side-port is located at a distance of about 0.090 inches (about 2.29 mm) from the electrode distal tip.


In typical embodiments of the first broad aspect, the insulation portion is configured to reduce abrasive friction between the device and the proximal edge of the side-port as the device is advanced through the side-port. In typical embodiments, the lumen terminates at the side-port. Typical embodiments include the needle comprising a single side-port operable for the device to travel therethrough. In some embodiments of the first broad aspect, the side-port is capsule-shaped. In some examples, a distal edge of the side-port includes a bevel. In some such examples, the bevel includes a combination of rounded and flat portions.


In some embodiments of the first broad aspect, the proximal edge of the side-port is beveled. In some embodiments, the guiding surface has a generally S-shaped surface.


As another feature of the first broad aspect, a distal end of the guiding surface is beveled, whereby the insulation portion which covers a proximal part of the side-port and the distal end of the guiding surface facilitate the device being guided out of a side of the needle and in a forward direction when advanced out of the side-port.


In accordance with an embodiment of the present invention, a method is disclosed for accessing a pericardial cavity, the method comprising the steps of: (1) contacting a pericardium with a needle, (2) tenting the pericardium with the needle and delivering energy through a blunt tip of the needle, (3) puncturing the pericardium with the needle and injecting a contrast flow into a pericardial cavity through a side-port of the needle, (4) advancing a guidewire through the needle and into the pericardial cavity, and (5) withdrawing the needle while leaving the guidewire in the pericardial cavity.


In accordance with an embodiment of the present invention, a method is disclosed for accessing a pericardial cavity, the method comprising the steps of: (1) contacting a pericardium with a needle, (2) tenting the pericardium with the needle and delivering energy through a blunt tip of the needle, (3) puncturing the pericardium with the needle and injecting a contrast flow into a pericardial cavity through a side-port of the needle, (4) advancing a small diameter guidewire into the pericardial cavity, (5) withdrawing the needle and advancing a dilator to dilate the puncture through the pericardium, (6) advancing a sheath over the dilator into pericardial cavity, (7) withdrawing the small diameter guidewire and advancing a relatively larger guidewire into the pericardial cavity, and (8) withdrawing the sheath.


In a further broad aspect, embodiments of the present invention are for a method having the steps of contacting a pericardium with a needle, using the needle for tenting the pericardium and delivering energy, using the needle for puncturing the pericardium and injecting a contrast flow into a pericardial cavity, advancing a guidewire (or other device) through the needle and into the pericardial cavity, and withdrawing the needle while leaving the guidewire (or other device) in the pericardial cavity.


As features of this aspect, some embodiments of the method further include the steps of advancing a mapping catheter or some other diagnostic device, and/or advancing an ablation catheter or some other treatment device, and/or placing leads or other medical devices.


With specific reference now to the drawings in detail, it is stressed that the particulars shown are by way of example and for purposes of illustrative discussion of certain embodiments of the present invention only. Before explaining at least one embodiment of the invention in detail, it is to be understood that the invention is not limited in its application to the details of construction and the arrangement of the components set forth in the following description or illustrated in the drawings. The invention is capable of other embodiments or of being practiced or carried out in various ways. Also, it is to be understood that the phraseology and terminology employed herein is for the purpose of description and should not be regarded as limiting.



FIG. 1A shows a top view of a needle 20 having a side-port 22 in elongate member 21. FIG. 1B shows a side view of the same needle with a guidewire 50 extending out of side-port 22. The side-port of FIGS. 1A and 1B is a slotted hole. The dimensions of the slot are dependent on the needle gauge and guidewire outer diameter. Some embodiments of needle 20 are 17 Ga, have a side-port width of about 0.036 inches (about 0.91 mm), a radius of about 0.018 inches (about 0.46 mm), a slot length of about 0.180 inches (about 4.57 mm), and can accommodate deployment and retraction of a 0.032 inches (about 0.81 mm) guidewire, and of guidewires having a smaller outer diameter. Such an embodiment may also accommodate, with a smaller clearance, a guidewire with an outer diameter of 0.035 inches (about 0.89 mm). Guidewires used in the disclosed method are typically comprised of spring stainless steel. In some embodiments, the distal tip of the guidewire is made of nitinol to provide a softer tip than steel. Some alternative embodiments comprise an insulated guidewire having a lubricous coating on the insulation. Embodiments of needle 20 typically have only a single side-port operable for advancing a guidewire (or another device) therethrough.


While this disclosure, for explanatory purposes, focuses on the use of needle 20 with guidewires, other devices can be advanced through needle, for example, flexible devices operable to delivery energy or monitor physiological variables.


The embodiment of the side-port 22 of FIG. 1A is a rounded slot or a slotted hole (i.e. capsule-shaped) having a constant side-port width. This configuration provides a flat wall with a minimal edge profile, thereby reducing the potential for generating debris when deploying or retracting a guidewire. Typically, side-port 22 and guidewire 50 are configured such that the clearance of the side-port 22 from the guidewire will be at least about 0.001 inches (about 0.025 mm). If using a smaller outer diameter guidewire, the clearance will be greater.


Detail A-V1 and detail A-V2 show alternative views for cut-away line A-A of FIG. 1A. Details A-V1 and A-V2 illustrate a guiding surface 24 (or ramp) within side-port 22, which functions to guide an advancing guidewire 50 through side-port 22. The guiding surface embodiment may be straight (e.g. detail A-V1) or curved (e.g. detail A-V2). The portion of guiding surface 24 visible from external side-view (from outside of the needle) has a length of about 0.020 inches (about 0.51 mm) for the embodiment of FIG. 1B. Please note, that while not all of the figures show a layer of insulation since it is not necessary for an understanding of the features illustrated by those figures, typical embodiments of needle 20 include insulation.


Guidewire 50 is placed under a bending moment when exiting the side port. To reduce this force, a bevel 26 (shown in FIG. 5) is located at the distal edge of side-port 22. In some embodiments, a bevel 26 of 10 degrees is located about 0.020 inches (about 0.51 mm) from the distal edge of side-port 22. Some such embodiments have been shown to be effective in reducing the bending moment. In some embodiments the bevel is generally flat, while in other embodiments the bevel is rounded, and in yet further embodiments the bevel includes a combination of rounded and flat portions.



FIG. 5 is a cut-away view including distal tip 34 of needle 20, wherein elongate member 21 defines lumen 28, guiding surface 24, and side-port 22. The embodiment of guiding surface 24 of FIG. 5 has a generally S-shaped surface. In general, side-port 22 is located close to the distal tip of the needle, which is advantageous for confirming the position of distal tip 34 because it allows contrast fluid to be delivered close to the needle's tip. In contrast, a device having a side-port that is relatively further away from the tip is more likely to encounter a situation where the side-port is still covered by tissue even though the distal tip has punctured a layer of tissue. A side-port 22 located close to the distal tip, in combination with the previously described bevel 26, also allows for a curved or T tip wire extended through side-port 22 to travel a short distance forward before curving, which prevents potential piercing of the epicardium with the wire tip. While a curved tip wire that easily bends or is floppy at the distal tip is advantageous for reducing unwanted tissue trauma, needle 20 may also be used with guidewire having a straight tip.



FIG. 1C is a cross-section showing a guidewire 50 that has been advanced through the lumen 28 and the side-port of needle 20. Enlarged sections C1 and C2 show guidewire 50 in contact with two different embodiments of the proximal edge 30 of side-port 22. Enlarged section C1 includes a proximal edge 30 having an approximately 90° angle. This angle is sharp enough to scrape a guidewire as it is advanced or retracted through the side-port, which may result in some debris creation. It is advantageous for proximal edge 30 to be beveled (as shown, for example, in enlarged section C2) to reduce debris generation when translating the guidewire through the needle. Some embodiments include a straight beveled edge, or a rounded bevel located about 0.020 inches (about 0.51 mm) from a proximal edge 30. In some such embodiments, these bevels have proven effective in reducing debris formation.



FIG. 1D illustrates needle 20 with insulation 32 (typically a polymer) covering the needle shaft, leaving an area around side-port 22 exposed, and a distal tip area exposed to define an electrode 36 which may be used for channeling into and puncturing tissue. In some alternative embodiments, insulation 32 is a ceramic.


Typical embodiments of needle 20 have an elongate member 21 (i.e. a main shaft) comprised of 304, 316 or 317 stainless steel, and an electrode 36 comprised of the same steel as the elongate member 21, with electrode 36 being dome welded. Alternative embodiments of elongate member 21 are comprised of other metals, including copper, titanium and nickel-titanium alloys, amongst others. In typical embodiments, energy (e.g. electricity) is delivered to electrode 36 through the metal side wall of needle 20. In some alternative embodiments, the needle's elongate member 21 is comprised of a stiff polymer and electrical energy is delivered to electrode 36 through an electrically conductive wire. Some alternative embodiments have an electrode 36 comprised, at least in part, of material more radiopaque than the elongate member such as platinum, platinum and Iridium alloys, gold, or silver to provide radiopaque visibility under fluoroscopy to determine the location of the needle's tip (i.e. the electrode has greater radiopacity than the elongate member). Such materials also improve reduction potential when collecting ECG data. Round tipped electrodes and the use of such round tipped electrodes for cutting tissue is described in U.S. Pat. No. 8,192,425, which is incorporated-by-reference herein in its entirety.


In one specific embodiment of needle 20, side-port 22 in elongate member 21 has a length of about 0.180 inches (about 4.57 mm), the distance between side-port 22 and electrode 36 is about 0.065 inches (about 1.65 mm), electrode 36 has a hemispherical shape with a radius of about 0.025 inches (about 0.64 mm), whereby distal tip 34 of needle 20 has an outer diameter of about 0.050 inches (about 1.25 mm), and there is distance of about 0.090 inches (about 2.29 mm) between electrode distal tip 37 (FIG. 1D) and side-port 22. In alternative embodiments, the distance between side-port 22 and electrode 36 is about 0.5 to 2 times the outer diameter of the needle tip; the length of side-port 22 depends on the inner diameter of the needle and the outer diameter of the an intended guide-wire, and ranges from about 0.1 to 0.2 inches, or about 2.54 to 5.08 mm (about the equivalent of 3 to 6 times the outer diameter of a 0.032 inch (about 0.81 mm) guidewire); the distance between electrode distal tip 37 and side-port 22 ranges from about about 0.050 to 0.125 inches (about 1.27 to 3.18 mm); and the electrode 36 has a size of about 22 to 17 Gauge (about 0.028 inches (about 0.71 mm) to about 0.058 inches (about 1.47 mm)). The electrode is large enough to provide bumper support against heart tissue.



FIG. 1D also illustrates insulation portion 32a, which covers a proximal part of side-port 22 to define an aperture 38 having a length of about 0.039 inches (about 0.99 mm). Aperture 38 is smaller than side-port 22 (uncovered). If contrast fluid is delivered through needle 20 under a constant lumen fluid pressure, the contrast will expel in a narrower stream and closer to the distal tip through an aperture 38 than through a relatively longer side-port 22.


Insulation portion 32a also reduces the amount of abrasive friction between guidewire 50 and proximal edge 30 of the side-port. First, while guidewire 50 can still rub against proximal edge 30 as it travels through the side-port, insulation portion 32a reduces the frictional forces between the guidewire and proximal edge 30. Second, when guidewire 50 travels through the side-port, it glides over insulation portion 32a, which is comprised of a polymer that is softer and less abrasive than the metal of the proximal edge 30. Insulation portion 32a further functions to direct an advancing guidewire forward, as to be further explained below.


In addition, insulation portion 32a reduces electrical leakage through side-port 22. In typical embodiments of needle 20 the tubular metal shaft tube is not insulated, which allows some electricity to leak out of the metal immediately adjacent to the side-port (i.e. metal forming the edge of the side-port), and some electricity to leak through fluid within the lumen and out of side-port 22. Insulation portion 32a covers some of the metal immediately adjacent the side-port to reduce electrical leakage therefrom. Insulation portion 32a also reduces the amount of fluid inside the lumen that is exposed to the environment outside the needle, thereby reducing electrical leakage through the fluid. Some alternative embodiments of needle 20 include insulation on an inner surface of the metal shaft tube in the area of the side-port (i.e. adjacent to) to reduce electrical leakage. Some other alternative embodiments include insulation on an inner surface of most or substantially all the metal shaft tube to reduce electrical leakage.


Another feature of needle 20 illustrated in FIG. 1D is that insulation 32 leaves a part of needle 20 adjacent to side-port 22 exposed to define elongate member exposed portion 20a. Another way to describe elongate member exposed portion 20a is that insulation 32 is trimmed back from the distal edge of side-port 22 to reduce the profile (or surface area) of the distal face of side-port 22. A reduced profile for the distal face allows a guidewire to exit the side-port at a reduced angle, i.e., closer to needle 20. Furthermore, including elongate member exposed portion 20a may help avoid a metallic guidewire adhering to insulation immediately adjacent to the side-port if a physician inadvertently electrifies the guidewire.



FIG. 2 illustrates an embodiment of needle 20 having a lubricious coating to enhance tactile feedback. FIGS. 2A to 2C show some of the uses of needle 20. FIG. 2A illustrates a guidewire 50 that has been advanced out of the side-port and is being advanced forwards. Guidewire 50 is guided forward by insulation portion 32a and bevel 26 of guiding surface 24. In more detail, the insulation portion 32a covers a proximal part of the side-port and a distal end of the guiding surface (or ramp) is beveled, whereby a device (e.g. a guidewire) is guided out of a side of the needle and in a forward direction when advanced out of the side-port. FIG. 2B illustrates contrast fluid injected using the side-port to create a contrast flow 52. FIG. 3 illustrates that a blunt tip comprised of electrode 36 can be used for ECG monitoring and recording. FIG. 4, consisting of FIGS. 4A-4F, illustrates some monitoring situations and the associated ECG signals. FIG. 7, consisting of FIGS. 7A-7D, shows ECG readings for different locations of the distal tip 34 of needle 20 within a pig to illustrate the advantage of ECG usage in identifying a puncture of a pericardium.


One method to fabricate a distal portion of a needle having the described geometry is to weld a metal billet, placed inside the needle lumen and flush with the needle's distal tip, to the distal end of the needle's metal shaft. The metal billet has a prefabricated guiding surface produced using milling or electrical discharge machining (EDM), and the needle shaft has a prefabricated side-port.


Another method to fabricate a distal portion of a needle is to first weld a solid metal billet flush with the distal tip of the needle's shaft, and then form the side port slot and guiding surface with an EDM electrode having a geometry corresponding to the side port and guiding surface.



FIG. 3 is an illustration showing an eight step method of using five devices, including a needle 20 disclosed herein. FIG. 3A shows a step 1 of contacting a pericardium 70 with needle 20. The heart is typically approached using a subxiphoid approach. Step 2 (FIG. 3B) includes tenting pericardium 70 with the needle and delivering energy (shown in broken line) through the blunt tip of needle 20. Step 3 (FIG. 3C) includes puncturing the pericardium 70 with the needle and injecting a contrast flow 52 into pericardial cavity 72 through a side-port of needle 20. In this example of the method, needle 20 is not touching myocardium 74, while in alternative embodiments, needle 20 touches but does not tent the myocardium 74. FIG. 3D illustrates step 4, advancing a small diameter guidewire 54 through the side-port and into the pericardial cavity 72. After the small diameter guidewire 54 is advanced, the method further includes a step 5 (FIG. 3E) of withdrawing needle 20 and advancing dilator 56 to dilate the puncture through pericardium 70. Sheath 58 may be advanced with dilator 56 or the sheath may be advanced afterwards to arrive at the illustration of FIG. 3E. Once the puncture is dilated, the method includes step 6 of advancing sheath 58 over the dilator into pericardial cavity 72 to arrive at the illustration of FIG. 3F. Step 7 includes withdrawing small diameter guidewire 54 and advancing guidewire 50 into pericardial cavity 72 (FIG. 3G). Step 8 (FIG. 3H) includes withdrawing the sheath, and leaving the guidewire 50 in pericardial cavity 72. In some embodiments guidewire 50 has a diameter of about 0.032 inches (about 0.813 mm) and small diameter guidewire 56 has a diameter of about 0.018 inches (about 0.46 mm). In some alternative embodiments, small diameter guidewire 56 has a diameter smaller than 0.018 inches (about 0.46 mm). Once guidewire 50 has been advanced into pericardial cavity 72 to provide access, other steps may include advancing a mapping catheter or some other diagnostic device, advancing an ablation catheter or some other treatment device, or placing leads or other medical devices.



FIG. 6 is an illustration showing a five-step method of using two devices, needle 20 and guidewire 50. Step 1 (FIG. 6A) includes contacting a pericardium 70 using needle 20. Step 2 (FIG. 6B) includes tenting pericardium 70 with the needle and delivering energy (shown in broken line) through the blunt tip of needle 20. Step 3 (FIG. 6C) includes puncturing the pericardium 70 with the needle and injecting a contrast flow 52 into pericardial cavity 72 through a side-port of needle 20. FIG. 6D illustrates a step 4 of advancing a guidewire 50 through the needle and into pericardial cavity 72. After the guidewire 50 is advanced, the method further includes a step 5 of withdrawing needle 20 while leaving guidewire 50 in pericardial cavity 72 to arrive at the illustration of FIG. 6E. In some embodiments guidewire 50 has a diameter of about 0.032 inches (about 0.813 mm). As with the above method, once guidewire 50 has been advanced into pericardial cavity 72 to provide access, other steps may include advancing a mapping catheter or some other diagnostic device, advancing an ablation catheter or some other treatment device, or placing leads or other medical devices for example at the epicardium. Guidewire used in the two above described methods may have a straight tip or a curved tip.


The embodiments of the invention described above are intended to be exemplary only. The scope of the invention is therefore intended to be limited solely by the scope of the appended claims.


It is appreciated that certain features of the invention, which are, for clarity, described in the context of separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the invention, which are, for brevity, described in the context of a single embodiment, may also be provided separately or in any suitable subcombination.


Although the invention has been described in conjunction with specific embodiments thereof, it is evident that many alternatives, modifications and variations will be apparent to those skilled in the art. Accordingly, it is intended to embrace all such alternatives, modifications and variations that fall within the broad scope of the appended claims. All publications, patents and patent applications mentioned in this specification are herein incorporated in their entirety by reference into the specification, to the same extent as if each individual publication, patent or patent application was specifically and individually indicated to be incorporated herein by reference. In addition, citation or identification of any reference in this application shall not be construed as an admission that such reference is available as prior art to the present invention.

Claims
  • 1. A needle for use with a device and for gaining epicardial access, the needle comprising: an elongate member which is comprised of a metal and defines a lumen and a side-port with a proximal edge, the side-port being in fluid communication with the lumen;an insulation covering an outside of the elongate member wherein a blunt tip of the needle is electrically exposed to define an electrode for delivering energy for puncturing tissue; anda guiding surface extending from a side wall of the elongate member which is opposite to the side-port to define an end of the lumen, the guiding surface configured for directing the device through the side-port;wherein the insulation includes an insulation portion covering a proximal part of the side-port defined by the elongate member to define an aperture which is smaller than the side-port, wherein the insulation portion is comprised of a polymer that is softer and less abrasive than the metal of the proximal edge.
  • 2. The needle of claim 1, wherein the needle is operable for delivering energy through a metal side wall of elongate member to the electrode.
  • 3. The needle of claim 2, wherein the electrode has greater radiopacity than the elongate member.
  • 4. The needle of claim 2, further comprising insulation on an inner surface of the elongate member adjacent to the side-port to reduce electrical leakage.
  • 5. The needle of claim 2, further comprising insulation on an inner surface of most or substantially all the elongate member to reduce electrical leakage.
  • 6. The needle of claim 2, wherein a part of the elongate member adjacent and distal of the side-port is electrically exposed to define an elongate member exposed portion.
  • 7. The needle of claim 2, wherein a distal edge of the side-port is located at a distance of about 0.050 to 0.125 inches (about 1.27 to 3.18 mm) from an electrode distal tip.
  • 8. The needle of claim 7, wherein the distal edge of the side-port is located at a distance of about 0.090 inches (about 2.29 mm) from the electrode distal tip.
  • 9. The needle of claim 1, wherein the insulation portion is configured to reduce abrasive friction between the device and the proximal edge of the side-port as the device is advanced through the side-port.
  • 10. The needle of claim 1, wherein the lumen terminates at the side-port.
  • 11. The needle of claim 1, wherein the needle comprises a single side-port operable for the device to travel therethrough.
  • 12. The needle of claim 1, wherein the side-port is capsule-shaped.
  • 13. The needle of claim 1, wherein a distal edge of the side-port includes a bevel.
  • 14. The needle of claim 13, wherein the bevel includes a combination of rounded and flat portions.
  • 15. The needle of claim 1, wherein the proximal edge of the side-port is beveled.
  • 16. The needle of claim 1, wherein the guiding surface has a generally S-shaped surface.
  • 17. The needle of claim 1, wherein a distal end of the guiding surface is beveled, whereby the insulation portion which covers a proximal part of the side-port and the distal end of the guiding surface facilitate the device being guided out of a side of the needle and in a forward direction when advanced out of the side-port.
CROSS REFERENCE TO RELATED APPLICATIONS

The present application is a continuation of U.S. patent application Ser. No. 15/754,030, filed Feb. 21, 2018, now U.S. Pat. No. 10,779,883, which is a national stage entry of PCT/IB2016/055404, filed Sep. 9, 2016, which claims priority to U.S. Provisional Application No. 62,216,059, filed Sep. 9, 2015, all of which are incorporated herein in their entireties.

US Referenced Citations (351)
Number Name Date Kind
175254 Oberly Mar 1876 A
827626 Gillet Jul 1906 A
848711 Weaver Apr 1907 A
1072954 Junn Sep 1913 A
1279654 Charlesworth Sep 1918 A
1918094 Geekas Jul 1933 A
1996986 Alexander Apr 1935 A
2021989 De Master Nov 1935 A
2146636 Lipchow Feb 1939 A
3429574 Williams Feb 1969 A
3448739 Stark et al. Jun 1969 A
3575415 Fulp et al. Apr 1971 A
3595239 Petersen Jul 1971 A
4129129 Amrine Dec 1978 A
4244362 Anderson Jan 1981 A
4401124 Guess et al. Aug 1983 A
4639252 Kelly et al. Jan 1987 A
4641649 Walinsky et al. Feb 1987 A
4669467 Willett et al. Jun 1987 A
4682596 Bales et al. Jul 1987 A
4774949 Fogarty Oct 1988 A
4790311 Ruiz Dec 1988 A
4790809 Kuntz Dec 1988 A
4793350 Mar et al. Dec 1988 A
4807620 Strul et al. Feb 1989 A
4832048 Cohen May 1989 A
4840622 Hardy Jun 1989 A
4863441 Lindsay et al. Sep 1989 A
4884567 Elliott et al. Dec 1989 A
4892104 Ito et al. Jan 1990 A
4896671 Cunningham et al. Jan 1990 A
4928693 Goodin et al. May 1990 A
4936281 Stasz Jun 1990 A
4960410 Pinchuk Oct 1990 A
4977897 Hurwitz Dec 1990 A
4998933 Eggers et al. Mar 1991 A
5006119 Acker et al. Apr 1991 A
5007908 Rydell Apr 1991 A
5019076 Yamanashi et al. May 1991 A
5047026 Rydell Sep 1991 A
5081997 Bosley et al. Jan 1992 A
5098431 Rydell Mar 1992 A
5112048 Kienle May 1992 A
5154724 Andrews Oct 1992 A
5163921 Feiring Nov 1992 A
5201756 Horzewski et al. Apr 1993 A
5209741 Spaeth May 1993 A
5211183 Wilson May 1993 A
5221256 Mahurkar Jun 1993 A
5230349 Langberg Jul 1993 A
5281216 Klicek Jan 1994 A
5300068 Rosar et al. Apr 1994 A
5300069 Hunsberger et al. Apr 1994 A
5314418 Takano et al. May 1994 A
5318525 West et al. Jun 1994 A
5327905 Avitall Jul 1994 A
5364393 Auth et al. Nov 1994 A
5372596 Klicek et al. Dec 1994 A
5380304 Parker Jan 1995 A
5397304 Truckai Mar 1995 A
5403338 Milo Apr 1995 A
5423809 Klicek Jun 1995 A
5425382 Golden et al. Jun 1995 A
5490859 Mische et al. Feb 1996 A
5497774 Swartz et al. Mar 1996 A
5507751 Goode et al. Apr 1996 A
5509411 Littmann et al. Apr 1996 A
5540681 Strul et al. Jul 1996 A
5545200 West et al. Aug 1996 A
5555618 Winkler Sep 1996 A
5558673 Edwards et al. Sep 1996 A
5571088 Lennox et al. Nov 1996 A
5575766 Swartz et al. Nov 1996 A
5575772 Lennox Nov 1996 A
5599347 Hart et al. Feb 1997 A
5605162 Mirzaee et al. Feb 1997 A
5617878 Taheri Apr 1997 A
5622169 Golden et al. Apr 1997 A
5624430 Eton et al. Apr 1997 A
5667488 Lundquist et al. Sep 1997 A
5673695 McGee et al. Oct 1997 A
5674208 Berg et al. Oct 1997 A
5683366 Eggers et al. Nov 1997 A
5720744 Eggleston et al. Feb 1998 A
5741249 Moss et al. Apr 1998 A
5766135 Terwilliger Jun 1998 A
5779688 Imran et al. Jul 1998 A
5810764 Eggers et al. Sep 1998 A
5814028 Swartz et al. Sep 1998 A
5827216 Igo et al. Oct 1998 A
5830214 Flom et al. Nov 1998 A
5836875 Webster, Jr. Nov 1998 A
5849011 Jones et al. Dec 1998 A
5851210 Torossian Dec 1998 A
5885227 Finlayson Mar 1999 A
5888201 Stinson et al. Mar 1999 A
5893848 Negus et al. Apr 1999 A
5893885 Webster, Jr. Apr 1999 A
5904679 Clayman May 1999 A
5916210 Winston Jun 1999 A
5921957 Killion et al. Jul 1999 A
5931818 Werp et al. Aug 1999 A
5944023 Johnson et al. Aug 1999 A
5951482 Winston et al. Sep 1999 A
5957842 Littmann et al. Sep 1999 A
5964757 Ponzi Oct 1999 A
5967976 Arsen et al. Oct 1999 A
5972013 Schmidt Oct 1999 A
5989276 Houser et al. Nov 1999 A
6007555 Devine Dec 1999 A
6009877 Edwards Jan 2000 A
6013072 Winston et al. Jan 2000 A
6017340 Cassidy et al. Jan 2000 A
6018676 Davis et al. Jan 2000 A
6030380 Auth et al. Feb 2000 A
6032674 Eggers et al. Mar 2000 A
6048349 Winston et al. Apr 2000 A
6053870 Fulton, III Apr 2000 A
6053904 Scribner et al. Apr 2000 A
6056747 Saadat et al. May 2000 A
6063093 Winston et al. May 2000 A
6093185 Ellis et al. Jul 2000 A
6106515 Winston et al. Aug 2000 A
6106520 Aufer et al. Aug 2000 A
6117131 Taylor Sep 2000 A
6142992 Cheng et al. Nov 2000 A
6146380 Racz Nov 2000 A
6155264 Ressemann et al. Dec 2000 A
6156031 Aita et al. Dec 2000 A
6162195 Igo et al. Dec 2000 A
6171305 Sherman Jan 2001 B1
6179824 Eggers et al. Jan 2001 B1
6193676 Winston et al. Feb 2001 B1
6193715 Wrublewski et al. Feb 2001 B1
6210408 Chandrasekaran et al. Apr 2001 B1
6217575 Devore et al. Apr 2001 B1
6221061 Engelson et al. Apr 2001 B1
6228076 Winston et al. May 2001 B1
6245054 Fuimaono et al. Jun 2001 B1
6267758 Daw et al. Jul 2001 B1
6283983 Makower et al. Sep 2001 B1
6292678 Hall et al. Sep 2001 B1
6293945 Parins et al. Sep 2001 B1
6296615 Brockway et al. Oct 2001 B1
6296636 Cheng et al. Oct 2001 B1
6302898 Edwards et al. Oct 2001 B1
6304769 Arenson et al. Oct 2001 B1
6315777 Comben Nov 2001 B1
6328699 Eigler et al. Dec 2001 B1
6360128 Kordis et al. Mar 2002 B2
6364877 Goble et al. Apr 2002 B1
6385472 Hall et al. May 2002 B1
6394976 Winston et al. May 2002 B1
6395002 Ellman et al. May 2002 B1
6419674 Bowser et al. Jul 2002 B1
6423051 Kaplan et al. Jul 2002 B1
6428551 Hall et al. Aug 2002 B1
6450989 Dubrul et al. Sep 2002 B2
6475214 Moaddeb Nov 2002 B1
6485485 Winston et al. Nov 2002 B1
6508754 Liprie et al. Jan 2003 B1
6524303 Garibaldi Feb 2003 B1
6530923 Dubrul et al. Mar 2003 B1
6554827 Chandrasekaran et al. Apr 2003 B2
6562031 Chandrasekaran et al. May 2003 B2
6562049 Norlander et al. May 2003 B1
6565562 Shah et al. May 2003 B1
6607529 Jones et al. Aug 2003 B1
6632222 Edwards et al. Oct 2003 B1
6639999 Cookingham et al. Oct 2003 B1
6650923 Lesh et al. Nov 2003 B1
6651672 Roth Nov 2003 B2
6662034 Segner et al. Dec 2003 B2
6663621 Winston et al. Dec 2003 B1
6666844 Igo et al. Dec 2003 B1
6702811 Stewart et al. Mar 2004 B2
6709444 Makower Mar 2004 B1
6723052 Mills Apr 2004 B2
6733511 Hall et al. May 2004 B2
6740103 Hall et al. May 2004 B2
6752800 Winston et al. Jun 2004 B1
6755816 Ritter et al. Jun 2004 B2
6770070 Balbierz Aug 2004 B1
6811544 Schaer Nov 2004 B2
6814733 Schwartz et al. Nov 2004 B2
6820614 Bonutti Nov 2004 B2
6834201 Gillies et al. Dec 2004 B2
6842639 Winston et al. Jan 2005 B1
6852109 Winston et al. Feb 2005 B2
6855143 Davison et al. Feb 2005 B2
6860856 Ward et al. Mar 2005 B2
6869431 Maguire et al. Mar 2005 B2
6911026 Hall et al. Jun 2005 B1
6951554 Johansen et al. Oct 2005 B2
6951555 Suresh et al. Oct 2005 B1
6955675 Jain Oct 2005 B2
6970732 Winston et al. Nov 2005 B2
6980843 Eng et al. Dec 2005 B2
7029470 Francischelli et al. Apr 2006 B2
7056294 Khairkhahan et al. Jun 2006 B2
7083566 Tornes et al. Aug 2006 B2
7112197 Hartley et al. Sep 2006 B2
7166104 Young Jan 2007 B2
7191015 Lamson et al. Mar 2007 B2
7229438 Young Jun 2007 B2
7335197 Sage et al. Feb 2008 B2
7618430 Scheib Nov 2009 B2
7651492 Wham Jan 2010 B2
7666203 Chanduszko et al. Feb 2010 B2
7678081 Whiting et al. Mar 2010 B2
7682360 Guerra Mar 2010 B2
7736347 Kaplan et al. Jun 2010 B2
7797059 Bornzin et al. Sep 2010 B1
7828796 Wong et al. Nov 2010 B2
7846088 Ness Dec 2010 B2
7900928 Held et al. Mar 2011 B2
8192425 Mirza et al. Jun 2012 B2
8211084 Kassab et al. Jul 2012 B2
8241276 Epstein Aug 2012 B2
8257323 Joseph et al. Sep 2012 B2
8282565 Mahapatra et al. Oct 2012 B2
8311648 Chitre et al. Nov 2012 B1
8317810 Stangenes et al. Nov 2012 B2
8388549 Paul et al. Mar 2013 B2
8475468 Leckrone et al. Jul 2013 B2
8500697 Kurth et al. Aug 2013 B2
8538555 Chitre et al. Sep 2013 B1
8603031 Callas et al. Dec 2013 B2
8874237 Schilling Oct 2014 B2
8906056 Gillies et al. Dec 2014 B2
8979842 McNall et al. Mar 2015 B2
8986278 Fung Mar 2015 B2
11339579 Stearns May 2022 B1
20010012934 Chandrasekaran et al. Aug 2001 A1
20010021867 Kordis et al. Sep 2001 A1
20020019644 Hastings et al. Feb 2002 A1
20020022781 McIntire et al. Feb 2002 A1
20020022836 Goble et al. Feb 2002 A1
20020035361 Houser et al. Mar 2002 A1
20020087153 Roschak et al. Jul 2002 A1
20020087156 Maguire et al. Jul 2002 A1
20020111618 Stewart et al. Aug 2002 A1
20020123749 Jain Sep 2002 A1
20020147485 Mamo et al. Oct 2002 A1
20020169377 Khairkhahan et al. Nov 2002 A1
20020188302 Berg et al. Dec 2002 A1
20020198521 Maguire Dec 2002 A1
20030032929 McGuckin Feb 2003 A1
20030040742 Underwood et al. Feb 2003 A1
20030144658 Schwartz et al. Jul 2003 A1
20030158480 Tornes et al. Aug 2003 A1
20030163153 Scheib Aug 2003 A1
20030187461 Chin Oct 2003 A1
20030225392 McMichael et al. Dec 2003 A1
20040015162 McGaffigan Jan 2004 A1
20040024396 Eggers Feb 2004 A1
20040030328 Eggers et al. Feb 2004 A1
20040044350 Martin et al. Mar 2004 A1
20040073243 Sepetka et al. Apr 2004 A1
20040077948 Violante et al. Apr 2004 A1
20040116851 Johansen et al. Jun 2004 A1
20040127963 Uchida et al. Jul 2004 A1
20040133113 Krishnan Jul 2004 A1
20040133130 Ferry et al. Jul 2004 A1
20040143256 Bednarek Jul 2004 A1
20040147950 Mueller et al. Jul 2004 A1
20040181213 Gondo Sep 2004 A1
20040230188 Cioanta et al. Nov 2004 A1
20050004585 Hall et al. Jan 2005 A1
20050010208 Winston et al. Jan 2005 A1
20050049628 Schweikert et al. Mar 2005 A1
20050059966 McClurken et al. Mar 2005 A1
20050065507 Hartley et al. Mar 2005 A1
20050085806 Auge et al. Apr 2005 A1
20050096529 Cooper et al. May 2005 A1
20050101984 Chanduszko et al. May 2005 A1
20050119556 Gillies et al. Jun 2005 A1
20050137527 Kunin Jun 2005 A1
20050149012 Penny et al. Jul 2005 A1
20050203504 Wham et al. Sep 2005 A1
20050203507 Truckai et al. Sep 2005 A1
20050261607 Johansen et al. Nov 2005 A1
20050261673 Bonner et al. Nov 2005 A1
20050288631 Lewis et al. Dec 2005 A1
20060041253 Newton et al. Feb 2006 A1
20060074398 Whiting et al. Apr 2006 A1
20060079769 Whiting et al. Apr 2006 A1
20060079787 Whiting et al. Apr 2006 A1
20060079884 Manzo et al. Apr 2006 A1
20060085054 Zikorus et al. Apr 2006 A1
20060089638 Carmel et al. Apr 2006 A1
20060106375 Werneth et al. May 2006 A1
20060135962 Kick et al. Jun 2006 A1
20060142756 Davies et al. Jun 2006 A1
20060189972 Grossman Aug 2006 A1
20060241586 Wilk Oct 2006 A1
20060247672 Vidlund et al. Nov 2006 A1
20060264927 Ryan Nov 2006 A1
20060276710 Krishnan Dec 2006 A1
20070060879 Weitzner et al. Mar 2007 A1
20070066975 Wong et al. Mar 2007 A1
20070118099 Trout May 2007 A1
20070123964 Davies et al. May 2007 A1
20070167775 Kochavi et al. Jul 2007 A1
20070208256 Marilla Sep 2007 A1
20070225681 House Sep 2007 A1
20070270791 Wang et al. Nov 2007 A1
20070293924 Belden et al. Dec 2007 A1
20080039865 Shaher et al. Feb 2008 A1
20080042360 Veikley Feb 2008 A1
20080086120 Mirza et al. Apr 2008 A1
20080097213 Carlson et al. Apr 2008 A1
20080108987 Bruszewski et al. May 2008 A1
20080146918 Magnin et al. Jun 2008 A1
20080171934 Greenan et al. Jul 2008 A1
20080208121 Youssef et al. Aug 2008 A1
20080275439 Francischelli et al. Nov 2008 A1
20090105742 Kurth et al. Apr 2009 A1
20090138009 Viswanathan et al. May 2009 A1
20090163850 Betts et al. Jun 2009 A1
20090171304 Cao Jul 2009 A1
20090177114 Chin et al. Jul 2009 A1
20090198252 Seifert et al. Aug 2009 A1
20090264977 Bruszewski et al. Oct 2009 A1
20100087789 Leeflang et al. Apr 2010 A1
20100125282 Machek et al. May 2010 A1
20100168684 Ryan Jul 2010 A1
20100179632 Bruszewski et al. Jul 2010 A1
20100191142 Paul et al. Jul 2010 A1
20100194047 Sauerwine Aug 2010 A1
20100331854 Greenberg et al. Dec 2010 A1
20110046619 Ducharme Feb 2011 A1
20110152716 Chudzik et al. Jun 2011 A1
20110160592 Mitchell Jun 2011 A1
20110190763 Urban et al. Aug 2011 A1
20120095434 Fung Apr 2012 A1
20120130366 Carroll et al. May 2012 A1
20120232546 Mirza et al. Sep 2012 A1
20120265055 Melsheimer et al. Oct 2012 A1
20120330156 Brown et al. Dec 2012 A1
20130085388 Stangenes Apr 2013 A1
20130184551 Paganelli et al. Jul 2013 A1
20130184735 Fischell et al. Jul 2013 A1
20130282084 Mathur et al. Oct 2013 A1
20140206987 Urbanski et al. Jul 2014 A1
20140296769 Hyde et al. Oct 2014 A1
20150216620 Davies Aug 2015 A1
20160220741 Garrison et al. Aug 2016 A1
20160242661 Fischell Aug 2016 A1
20190021763 Zhou et al. Jan 2019 A1
20190247035 Gittard et al. Aug 2019 A1
Foreign Referenced Citations (6)
Number Date Country
2015128637 Jul 2015 JP
2015518752 Jul 2015 JP
WO9904851 Feb 1999 WO
WO2014141197 Sep 2014 WO
WO2015114560 Aug 2015 WO
WO2015130987 Sep 2015 WO
Non-Patent Literature Citations (7)
Entry
Supplementary Partial European Search Report for counterpart to parent application European Application No. EP16843791, dated Apr. 30, 2019.
First Office Action for Chinese counterpart to parent application Chinese Patent Application 2016800519082.
Translation of First Office Action for Chinese counterpart to parent application Chinese Patent Application 2016800519082.
First Office Action (Notice of Reasons for Rejection) for Japanese counterpart to parent application Japanese Patent Application 2018-510111.
Translation of First Office Action (Notice of Reasons for Rejection) for Japanese counterpart to parent application Japanese Patent Application 2018-510111.
International Search Report and Written Opinion received for PCT Patent Application No. PCT/IB2016/055404, dated Dec. 8, 2016, 11 pages.
Patent Cooperation Treaty, International Preliminary Report on Patentability, International Application No. PCT/IB2016/055404, dated Dec. 8, 2016.
Related Publications (1)
Number Date Country
20200397503 A1 Dec 2020 US
Provisional Applications (1)
Number Date Country
62216059 Sep 2015 US
Continuations (1)
Number Date Country
Parent 15754030 US
Child 17014144 US